These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 20163014)
1. [A questionnaire study on the necessity of approval for revaccination of the pneumococcal polysaccharide vaccine]. Oishi K; Kawakami K; Nagai H; Sunakawa K; Watanabe A Nihon Kokyuki Gakkai Zasshi; 2010 Jan; 48(1):5-9. PubMed ID: 20163014 [TBL] [Abstract][Full Text] [Related]
2. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults. Musher DM; Manof SB; Liss C; McFetridge RD; Marchese RD; Bushnell B; Alvarez F; Painter C; Blum MD; Silber JL J Infect Dis; 2010 Feb; 201(4):516-24. PubMed ID: 20092407 [TBL] [Abstract][Full Text] [Related]
3. A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) revaccination coverage rate among elderly adults aged 65 and older and physician's attitude. Nakamura A; Kawakami K; Wakana A; Folaranmi TA; Iino T Hum Vaccin Immunother; 2020 Sep; 16(9):2292-2299. PubMed ID: 32045317 [TBL] [Abstract][Full Text] [Related]
4. Reactions after 3 or more doses of pneumococcal polysaccharide vaccine in adults in Alaska. Walker FJ; Singleton RJ; Bulkow LR; Strikas RA; Butler JC Clin Infect Dis; 2005 Jun; 40(12):1730-5. PubMed ID: 15909258 [TBL] [Abstract][Full Text] [Related]
5. Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia. Törling J; Hedlund J; Konradsen HB; Ortqvist A Vaccine; 2003 Dec; 22(1):96-103. PubMed ID: 14604576 [TBL] [Abstract][Full Text] [Related]
6. Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine. Smets F; Bourgois A; Vermylen C; Brichard B; Slacmuylders P; Leyman S; Sokal E Vaccine; 2007 Jul; 25(29):5278-82. PubMed ID: 17576024 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan. Kawakami K; Ohkusa Y; Kuroki R; Tanaka T; Koyama K; Harada Y; Iwanaga K; Yamaryo T; Oishi K Vaccine; 2010 Oct; 28(43):7063-9. PubMed ID: 20723631 [TBL] [Abstract][Full Text] [Related]
8. Safety of revaccination with pneumococcal polysaccharide vaccine. Jackson LA; Benson P; Sneller VP; Butler JC; Thompson RS; Chen RT; Lewis LS; Carlone G; DeStefano F; Holder P; Lezhava T; Williams WW JAMA; 1999 Jan; 281(3):243-8. PubMed ID: 9918479 [TBL] [Abstract][Full Text] [Related]
9. Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study. Jackson LA; Baxter R; Naleway AL; Belongia EA; Baggs J BMC Infect Dis; 2009 Mar; 9():37. PubMed ID: 19321001 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous vaccination of Chinese applicants for a United States immigrant visa. Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068 [TBL] [Abstract][Full Text] [Related]
11. Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study. Hechter RC; Chao C; Jacobsen SJ; Slezak JM; Quinn VP; Van Den Eeden SK; Tseng HF Vaccine; 2012 Aug; 30(38):5625-30. PubMed ID: 22789510 [TBL] [Abstract][Full Text] [Related]
12. Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years. Manoff SB; Liss C; Caulfield MJ; Marchese RD; Silber J; Boslego J; Romero-Steiner S; Rajam G; Glass NE; Whitney CG; Carlone GM J Infect Dis; 2010 Feb; 201(4):525-33. PubMed ID: 20088694 [TBL] [Abstract][Full Text] [Related]
13. Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population. Jackson LA; Nelson JC; Whitney CG; Neuzil KM; Benson P; Malais D; Baggs J; Mullooly J; Black S; Shay DK Vaccine; 2006 Jan; 24(2):151-6. PubMed ID: 16122845 [TBL] [Abstract][Full Text] [Related]
14. Assessing pneumococcal revaccination safety among New York State Medicare beneficiaries. Shih A; Quinley J; Lee TK; Messina CR Public Health Rep; 2002; 117(2):164-73. PubMed ID: 12357001 [TBL] [Abstract][Full Text] [Related]